MI
Milton C Ault Iii (Executive Chairman) filed 17 Form 4 reports in the trailing twelve months (17 purchases, 0 sales, 2 filed past the two-business-day deadline), most often in Alzamend Neuro, Inc. (ALZN). Across 13 priced purchase filings, the average 21-session return was -0.1% from execution and +1.8% from disclosure (delay-adjusted; derived). The largest single filing was $5.0M of GPUS (10,000,000 sh × $0.50, as filed), executed Sep 30. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-0.1%
avg across 13 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+1.8%
same 13 filings, from disclosure
Filings, ttm
17
17 buys · 0 sells · 2 late
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$10.7M
shares × price, as filed
Last traded
Sep 30
Filed Oct 1
Median ADV $261K across their filed names
Impact on $10,000 · 12M
$12,235 (+22.3%)
S&P 500 $10,907 (+9.1%) · 13.3 pts ahead
Milton C Ault Iii
S&P 500
Derived: compounded across filings from disclosure dates · past 12 months
Open performance→Volume by month
Buys $10.7M
Sells $1.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Industrials
14 filings
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
ALZNRecent filings
ALZNSALE
Alzamend Neuro, Inc.
View filing →
$176K59,516 sh × $2.95
Exec Jul 23 2025
Filed Jul 25 2025 · 5:30 PM ET